American Well Co. (NYSE:AMWL – Get Free Report) insider Kathy Johnson Weiler sold 7,266 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.87, for a total transaction of $57,183.42. Following the transaction, the insider now owns 188,027 shares of the company’s stock, valued at approximately $1,479,772.49. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
American Well Stock Up 2.7 %
Shares of AMWL opened at $8.00 on Friday. The firm has a 50-day moving average price of $8.10 and a 200 day moving average price of $11.39. The firm has a market capitalization of $118.58 million, a PE ratio of -0.33 and a beta of 1.04. American Well Co. has a 52-week low of $5.00 and a 52-week high of $31.60.
American Well (NYSE:AMWL – Get Free Report) last announced its earnings results on Wednesday, July 31st. The company reported ($3.36) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($3.94) by $0.58. American Well had a negative net margin of 120.44% and a negative return on equity of 50.36%. The firm had revenue of $62.79 million during the quarter, compared to analyst estimates of $60.78 million. During the same quarter in the prior year, the firm posted ($4.60) EPS. On average, equities analysts expect that American Well Co. will post -13.91 EPS for the current year.
Institutional Investors Weigh In On American Well
Wall Street Analyst Weigh In
Several research firms have recently commented on AMWL. Wells Fargo & Company lowered their price target on shares of American Well from $40.00 to $15.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 6th. UBS Group decreased their target price on shares of American Well from $30.00 to $12.00 and set a “neutral” rating for the company in a research report on Thursday, May 23rd. Finally, Needham & Company LLC reiterated a “hold” rating on shares of American Well in a research report on Thursday, August 1st.
Check Out Our Latest Report on American Well
About American Well
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Further Reading
- Five stocks we like better than American Well
- Are Penny Stocks a Good Fit for Your Portfolio?
- Does GTA VI Make Take-Two Interactive Stock an Irresistible Buy?
- How to Plot Fibonacci Price Inflection Levels
- Why HPE’s Dip Is a Prime Opportunity for Blue-Chip AI Investors
- What Does Downgrade Mean in Investing?
- Why Analysts See Big Upside for Occidental Petroleum Despite Lows
Receive News & Ratings for American Well Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Well and related companies with MarketBeat.com's FREE daily email newsletter.